Published in:
01-11-2013 | Clinical Research
Trabecular Metal in Total Knee Arthroplasty Associated with Higher Knee Scores: A Randomized Controlled Trial
Authors:
Mariano Fernandez-Fairen, MD, PhD, Daniel Hernández-Vaquero, MD, PhD, Antonio Murcia, MD, PhD, Ana Torres, MD, PhD, Rafael Llopis, MD, PhD
Published in:
Clinical Orthopaedics and Related Research®
|
Issue 11/2013
Login to get access
Abstract
Background
Porous tantalum is an option of cementless fixation for TKA, but there is no randomized comparison with a cemented implant in a mid-term followup.
Questions/purposes
We asked whether a tibial component fixed by a porous tantalum system might achieve (1) better clinical outcome as reflected by the Knee Society Score (KSS) and WOMAC Osteoarthritis Index, (2) fewer complications and reoperations, and (3) improved radiographic results with respect to aseptic loosening compared with a conventional cemented implant.
Methods
We randomized 145 patients into two groups, either a porous tantalum cementless tibial component group (Group 1) or cemented conventional tibial component in posterior cruciate retaining TKA group (Group 2). Patients were evaluated preoperatively and 15 days, 6 months, and 5 years after surgery, using the KSS and the WOMAC index. Complications, reoperations, and radiographic failures were tallied.
Results
At 5-year followup the KSS mean was 90.4 (range, 68–100; 95% CI, ± 1.6) for Group 1, and 86.5 (range, 56–99; 95% CI, ± 2.4) for Group 2. The effect size, at 95% CI for the difference between means, was 3.88 ± 2.87. The WOMAC mean was 15.1 (range, 0–51; 95% CI, ± 2.6) for the Group 1, and 19.1 (range, 4–61; 95% CI, ± 2.9) for Group 2. The effect size for WOMAC was −4.0 ± 3.9. There were no differences in the frequency of complications or in aseptic loosening between the two groups.
Conclusions
Our data suggest there are small differences between the uncemented porous tantalum tibial component and the conventional cemented tibial component. It currently is undetermined whether the differences outweigh the cost of the implant and the results of their long-term performance.
Level of Evidence
Level I, therapeutic study. See Instructions to Authors for a complete description of levels of evidence.